• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撤回:肠型核梭杆菌、脆弱拟杆菌和大肠埃希菌对结直肠癌 5-氟尿嘧啶耐药性诊断性能的比较:一项荟萃分析。

RETRACTED: Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis.

机构信息

Beijing Friendship Hospital, Capital Medical University Beijing,100050 China.

Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing,100053 China.

出版信息

Cancer Treat Res Commun. 2022;32:100536. doi: 10.1016/j.ctarc.2022.100536. Epub 2022 Feb 22.

DOI:10.1016/j.ctarc.2022.100536
PMID:35567912
Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the authors, as the current findings are incomplete and need to be validated. The reasons include that the results are not comparable to the diagnostic performance of three bacteria species in 5-fluorouracil resistance in CRC from the clinical studies which are conducted to detect each type of bacteria separately. Additional results of quantifying three bacteria species in the same colorectal cancer group are required to validate the conclusion.

摘要

本文已被撤回

请参阅爱思唯尔关于文章撤回的政策(https://www.elsevier.com/about/our-business/policies/article-withdrawal)。应作者要求,本文已被撤回,因为目前的研究结果并不完整,需要验证。原因包括,这些结果与在临床研究中检测每种细菌时检测到的 5-氟尿嘧啶耐药性 CRC 中三种细菌的诊断性能不可比。需要对同一结直肠癌组中的三种细菌进行定量,以验证该结论。

相似文献

1
RETRACTED: Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis.撤回:肠型核梭杆菌、脆弱拟杆菌和大肠埃希菌对结直肠癌 5-氟尿嘧啶耐药性诊断性能的比较:一项荟萃分析。
Cancer Treat Res Commun. 2022;32:100536. doi: 10.1016/j.ctarc.2022.100536. Epub 2022 Feb 22.
2
The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota.癌症化疗药物 5-氟尿嘧啶是一种有效的具核梭杆菌抑制剂,其活性可被肿瘤内微生物群改变。
Cell Rep. 2022 Nov 15;41(7):111625. doi: 10.1016/j.celrep.2022.111625.
3
Association between Bacteroides fragilis and Fusobacterium nucleatum infection and colorectal cancer in Vietnamese patients.脆弱拟杆菌和具核梭杆菌感染与越南患者结直肠癌的相关性。
Anaerobe. 2024 Aug;88:102880. doi: 10.1016/j.anaerobe.2024.102880. Epub 2024 Jun 26.
4
[The Relationship of Enterotoxigenic Bacteroides fragilis and Fusobacterium nucleatum Intestinal Colonization with Colorectal Cancer: A Case-Control Study Performed with Colon Biopsies].[产肠毒素脆弱拟杆菌和具核梭杆菌肠道定植与结直肠癌的关系:一项通过结肠活检进行的病例对照研究]
Mikrobiyol Bul. 2023 Jul;57(3):353-364. doi: 10.5578/mb.20239929.
5
Intratumoral presence of the genotoxic gut bacteria pks E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer.肿瘤内存在基因毒性肠道细菌 pks E. coli、产肠毒素脆弱拟杆菌和具核梭杆菌及其与结直肠癌的临床病理和分子特征的关联。
Br J Cancer. 2024 Mar;130(5):728-740. doi: 10.1038/s41416-023-02554-x. Epub 2024 Jan 10.
6
Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.具核梭杆菌通过上调结直肠癌中 BIRC3 的表达促进氟尿嘧啶的化疗耐药性。
J Exp Clin Cancer Res. 2019 Jan 10;38(1):14. doi: 10.1186/s13046-018-0985-y.
7
Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.检测结直肠癌肿瘤中的具核梭杆菌和脆弱拟杆菌:最佳靶标部位及与总细菌负荷的相关性。
PLoS One. 2022 Jan 7;17(1):e0262416. doi: 10.1371/journal.pone.0262416. eCollection 2022.
8
Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.伊朗患者中结直肠癌与具核梭杆菌和脆弱拟杆菌之间的关联:一项初步研究。
Infect Agent Cancer. 2021 Jun 9;16(1):41. doi: 10.1186/s13027-021-00381-4.
9
The Role of Fecal and as Early Diagnostic Markers of Colorectal Cancer.粪便 和 的作用:结直肠癌的早期诊断标志物。
Dis Markers. 2021 Nov 22;2021:1171239. doi: 10.1155/2021/1171239. eCollection 2021.
10
Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085.具核梭杆菌感染的结肠癌细胞分泌的外泌体通过传递 hsa_circ_0004085 来传递对奥沙利铂和 5-FU 的耐药性。
J Nanobiotechnology. 2024 Feb 15;22(1):62. doi: 10.1186/s12951-024-02331-9.

引用本文的文献

1
Fecal microbial biomarkers combined with multi-target stool DNA test improve diagnostic accuracy for colorectal cancer.粪便微生物生物标志物联合多靶点粪便DNA检测可提高结直肠癌的诊断准确性。
World J Gastrointest Oncol. 2023 Aug 15;15(8):1424-1435. doi: 10.4251/wjgo.v15.i8.1424.
2
Treatment of colorectal cancer by anticancer and antibacterial effects of hemiprotonic phenanthroline-phenanthroline with nanomicelle delivery.通过具有纳米胶束递送功能的半质子化菲咯啉-菲咯啉的抗癌和抗菌作用治疗结直肠癌。
Asian J Pharm Sci. 2023 May;18(3):100801. doi: 10.1016/j.ajps.2023.100801. Epub 2023 Mar 28.
3
: a novel immune modulator in breast cancer?
: 一种新型乳腺癌免疫调节剂?
Expert Rev Mol Med. 2023 Apr 3;25:e15. doi: 10.1017/erm.2023.9.